Devices

Scott Abbott is the Director of Medical Development at Valeritas. He shares information from his presentation at the ADA on how the V-Go insulin delivery device can be used in the real world.

Dr. Scott Abbott discusses the V-Go wearable insulin delivery device, which is like a wearable insulin pen; it uses rapid-acting insulin and is approved as a pump-like device.

In this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about the use, benefits, and future of the V-Go insulin delivery system.

In part 1 of this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about how the V-Go insulin delivery system can be used in diabetes patients in real world settings.

In part 2 of this Exclusive Interview, Scott Abbott explains how the V-Go insulin delivery device works in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 3 of this Exclusive Interview, Scott Abbott explains how to adjust the insulin dosage using the V-Go insulin delivery system in a talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 4 of this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about how studies have proven the effectiveness of the V-Go device.

In part 5 of this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about the other benefits of using the V-Go system.

In part 6 of this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the positive factors of V-Go and the patients who can use it.

In part 7 of this Exclusive Interview, Scott Abbott shares what's next on the V-Go front in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.